Displaying drugs 14576 - 14600 of 15480 in total
FR236913
Experimental
Indole-3-Propanol Phosphate
Experimental
RU79073
Experimental
2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol
Experimental
Fe-Mesopone
Experimental
VX-702
VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.
Investigational
4-O-Demethylpenclomedine
Investigational
5-Bromoindirubin
Experimental
2-heptyl-4-hydroxyquinoline N-oxide
Experimental
Indoleacetamide
Experimental
9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE
Experimental
Indalpine
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Description: … However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported …
Piromelatine
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Displaying drugs 14576 - 14600 of 15480 in total